Through P&C’s collaboration with Akron Children’s Hospital in Ohio, a new neonatal clonidine formulation has been created using QuartetRx®. The formulation employs 0.3 mg clonidine tablets in water and simple syrup yielding a final concentration of 20 mcg/ml. Formulation and stability data presented at the 2019 ASHP Midyear meeting in December suggest that QuartetRx provides a viable system for compounding this essential formulation for neonatal patients.
– Akron Children’s Hospital in Akron, OH